Long-Term Hepatic Vascular Access in the Nonhuman Primate for Recurrent Portal Vein Infusion

REFERENCES

• Shapiro AM, Ricordi C, Hering BJ, International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355(13):1318–1330.
   PubMed Web of Science ®Google Scholar
• Hirshberg B, Mog S, Patterson N, Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using Edmonton protocol immunosuppression. J Clin Endocrinol Metab. 2002;87(12):5424–5429.
   Google Scholar
• Hirshberg B, Montgomery S, Wysoki MG, Pancreatic islet transplantation using the nonhuman primate (Rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site. Diabetes 2002;51(7):2135–2140.
   Google Scholar
• Kenyon NS, Fernandez LA, Lehmann R, Long-term survival and function of intrahepatic islet allografts in Baboons treated with humanized anti-CD154. Diabetes 1999;48:1473–1481.
   PubMed Web of Science ®Google Scholar
• Cardona K, Korbutt GS, Milas Z, Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med. 2006;12(3):304–306.
   PubMed Web of Science ®Google Scholar
• Hering BJ, Wijkstrom M, Graham ML, Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med. 2006;12(3):301–303.
   PubMed Web of Science ®Google Scholar
• Vons C, Beaudoin S, Helmy N, First description of the surgical anatomy of the cynomolgus monkey liver. Am J Primatol. 2009;71(5):400–4008.
   Google Scholar
• Cooper DKC, Casu A. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes—chapter 4: pre-clinical efficacy and complication data required to justify a clinical trial. Xenotransplantation 2009;16(4):229–238.
   Web of Science ®Google Scholar
• National Research Council, Institute for Laboratory Animal Resources. Guide for the Care and Use of Laboratory Animals. Washington, D.C., National Academies Press; 1996.
   Google Scholar
• Graham ML, Rieke EF, Dunning M, A novel alternative placement site and technique for totally implantable vascular access ports in non-human primates. J Med Primatol. 2009;38(3):204–212.
   PubMed Web of Science ®Google Scholar
• Gray H. Anatomy of the Human Body. Philadelphia: Lea & Febiger, 1918; Bartleby.com, 2000.
   Google Scholar
• Badia JM, Whawell SA, Scott-Coombes DM, Peritoneal and systemic cytokine response to laparotomy. Br J Surg. 1996;83(3):347–348.
   PubMed Web of Science ®Google Scholar
• Viswanathan K, Dhabhar FS. Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proc Natl Acad Sci USA 2005;102(16):5808–5813.
   Google Scholar
• Beilin B, Shavit Y, Trabekin E, The effects of postoperative pain management on immune response to surgery. Anesth Analg. 2003;97(3):822–827.
   PubMed Web of Science ®Google Scholar
• Andreoletti M, Loux N, Vons C, Engraftment of autologous retrovirally transduced hepatocytes after intraportal transplantation into nonhuman primates: implication for ex vivo gene therapy. Hum Gene Ther. 2001;12(2):169–179.
   Google Scholar
• Vons C, Loux N, Simon L, Transplantation of hepatocytes in nonhuman primates: a preclinical model for the treatment of hepatic metabolic diseases. Transplantation 2001;72(5):811–818.
   Google Scholar
• Scalese RJ, DeForrest JM, Hammerstone S, Long term vascular catheterization of the cynomolgus monkey. Lab Anim Sci. 1990;40(5):530–532.
   Google Scholar
• Ohta M, Hashizume M, Kawanaka H, Complications of percutaneous transhepatic catheterization of the portal venous system in patients with portal hypertension. J Gastroenterol Hepatol. 1996;11(7):630–634.
   Google Scholar
• Shapiro AM, Lakey JR, Ryan EA, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230–238.
   PubMed Web of Science ®Google Scholar
• Owen RJ, Ryan EA, O'Kelly K, Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology 2003;229(1):165–170.
   Google Scholar
• Maleux G, Gillard P, Keymeulen B, Feasibility, safety, and efficacy of percutaneous transhepatic injection of beta-cell grafts. J Vasc Interv Radiol. 2005;16(12):1693–1697.
   Web of Science ®Google Scholar
• Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol. 2005;77(5):587–597.
   PubMed Web of Science ®Google Scholar
• Wang X, Alfrey EJ, Posselt A, Tafra L, Alak AM, Dafoe DC. Intraportal delivery of immunosuppression to intrahepatic islet allograft recipients. Transplant Int. 1995;8(4):268–272.
   Google Scholar